Abstract
In recent years, treatments for gastrointestinal malignant tumors have attracted a lot of attention. However, due to size limitations and the working environment of gastrointestinal peristalsis, traditional treatment methods have poor efficacy. Herein, we proposed a novel drug release method of piezoelectric actuation combined with ultrasound in the endoscope biopsy channel. A bidirectional piezoelectric actuator was manufactured and inserted into the endoscope with an ultrasonic transducer, adjusting the distance between the transducer and the lesion. A gastric mucosa phantom was fabricated and a finite element (FE) model was established for ultrasound thermal calculation. For enhancing the drug release rate, a pulse-echo method was conducted using a Laboratory Virtual Instrument Engineering Workbench (LabVIEW) program for real-time monitoring and feedback. The results of FEM calculations show that the temperature in the phantom can reach the melting-phase transition temperature of the TSL (41 ± 1 °C). The drug release rate can increase from 2.2 × 10−4 mg min−1 to 39.2 × 10−4 mg min−1 with our actuator, the latter is nearly 18 times the former. Furthermore, the drug release rate can be increased to a maximum value of 45.8 × 10−4 mg min−1 by optimizing the driving parameter of our actuator. Therefore, our method has a bright application in targeted drug delivery of major gastrointestinal diseases in the future.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.